MoonLake Immunotherapeutics (MLTX) Key Ratios
$14.91
$-0.28
(-1.84%)
As on 04-Sep-2026 13:36EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | 11.57 | -9.58 | -43.79 | -236.76 | -576.13 |
| Net Profit | 11.34 | -13.64 | -416.81 | -173.37 | -578.19 |
| EPS | 14.50 | 4.18 | -39.17 | -243.25 | -456.11 |
| Book Value | -- | -- | -33.33 | 55.39 | -9.07 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | -10,901.23 | -- | -- | -- |
| Return on equity
| -32.99 | -90.86 | -71.55 | -60.51 | -25.24 |
| Return on Capital
| -30.99 | -69.28 | -- | -54.79 | -25.06 |
| Return on Assets
| -28.67 | -48.46 | -32.32 | -50.38 | -23.68 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.25 | 0.01 |
The underlying data is unavailable.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
